Concepedia

Christopher Ho

CH

7

Publications

1.4K

Citations

7

H-Index

2004

Active since

Affiliations

University of California, San Francisco(Current)

University of California, Irvine

University of Mississippi

Kern Medical Center

Czech Academy of Sciences, Institute of Physiology

Christopher Ho is an author at University of California, San Francisco specializing in medicine, metabolic syndrome, and diabetes.

Top concepts

MedicineDiabetesPharmacologyPharmacotherapyMetabolic SyndromeMolecular PharmacologyHealthPhysiologyBiochemistryCell Biology

Publications per year

2004–2011

7

Publications

7

Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity

Stephen C. Benson, Harrihar A. Pershadsingh, Christopher Ho et al. · Hypertension · 2004 · 1.1K citations

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +17

Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains

Michal Pravenec, Masaya Hyakukoku, J Houštěk et al. · Genome Research · 2007 · 88 citations · Full text

Genetics, Genetic Epidemiology, Molecular Genetics +19

Molecular and cellular effects of azilsartan

Takashi Kajiya, Christopher Ho, Jiaming Wang et al. · Journal of Hypertension · 2011 · 61 citations

Rosiglitazone Inhibits Proliferation, Motility, and Matrix Metalloproteinase Production in Keratinocytes

Narasimharao Bhagavathula, Kamalakar C. Nerusu, Ashish Lal et al. · Journal of Investigative Dermatology · 2004 · 58 citations · Full text

Biochemistry, Natural Sciences, Lipid Peroxidation +9

Design and Synthesis of the First Generation of Dithiolane Thiazolidinedione- and Phenylacetic Acid-Based PPARγ Agonists

Amar G. Chittiboyina, M.S. Venkatraman, Cássia S. Mizuno et al. · Journal of Medicinal Chemistry · 2006 · 52 citations · Full text

Nutraceutical Ingredient, Lipid Peroxidation, Pharmacotherapy +18

Rows per page

1–5 of 7